Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:GEN

Genesis Healthcare (GEN) Stock Price, News & Analysis

Genesis Healthcare logo

About Genesis Healthcare Stock (NYSE:GEN)

Advanced Chart

Key Stats

Today's Range
$28.65
$29.56
50-Day Range
$0.18
$0.60
52-Week Range
$0.40
$1.37
Volume
2.75 million shs
Average Volume
4.10 million shs
Market Capitalization
$18.34 billion
P/E Ratio
31.88
Dividend Yield
1.74%
Price Target
$33.25
Consensus Rating
Moderate Buy

Company Overview

Genesis Healthcare Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
28th Percentile Overall Score

GEN MarketRank™: 

Genesis Healthcare scored higher than 28% of companies evaluated by MarketBeat, and ranked 232nd out of 317 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Genesis Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Genesis Healthcare has received no research coverage in the past 90 days.

  • Read more about Genesis Healthcare's stock forecast and price target.
  • Earnings Growth

    Earnings for Genesis Healthcare are expected to grow by 5.52% in the coming year, from $1.63 to $1.72 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Genesis Healthcare is 31.88, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.90.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Genesis Healthcare is 31.88, which means that it is trading at a more expensive P/E ratio than the Business Services sector average P/E ratio of about 28.44.

  • Short Interest

    There is no current short interest data available for GEN.
  • Dividend Yield

    Genesis Healthcare pays a meaningful dividend of 3.05%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Genesis Healthcare does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Genesis Healthcare is 55.56%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Genesis Healthcare will have a dividend payout ratio of 29.07% next year. This indicates that Genesis Healthcare will be able to sustain or increase its dividend.

  • Read more about Genesis Healthcare's dividend.
  • Short Interest

    There is no current short interest data available for GEN.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Genesis Healthcare this week, compared to 3 articles on an average week.
  • Search Interest

    4 people have searched for GEN on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Genesis Healthcare insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.30% of the stock of Genesis Healthcare is held by insiders.

  • Percentage Held by Institutions

    82.08% of the stock of Genesis Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Genesis Healthcare's insider trading history.
Receive GEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genesis Healthcare and its competitors with MarketBeat's FREE daily newsletter.

GEN Stock News Headlines

Nursing home operator Genesis Healthcare files for bankruptcy
AI Meltdown Imminent: Dump These Stocks Now!
If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.
Genesis Healthcare files for bankruptcy
Luxury!; 2025 Genesis G80 3.5T
See More Headlines

GEN Stock Analysis - Frequently Asked Questions

Genesis Healthcare, Inc. (NYSE:GEN) released its earnings results on Thursday, August, 1st. The company reported $0.53 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.53. The company's quarterly revenue was up 2.3% on a year-over-year basis.

Genesis Healthcare's Board of Directors authorized a stock repurchase plan on Thursday, May 9th 2024, which authorizes the company to repurchase $3,000,000,000 in outstanding shares, according to EventVestor. This means that the company could buy up to 23.1% of its stock through open market purchases. Stock buyback plans are generally a sign that the company's management believes its shares are undervalued.

Based on aggregate information from My MarketBeat watchlists, some other companies that Genesis Healthcare investors own include Invesco QQQ (QQQ), NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
8/01/2024
Today
7/12/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NYSE:GEN
Previous Symbol
NYSE:SKH
CIK
849399
Employees
2,700
Year Founded
N/A

Price Target and Rating

High Price Target
$37.00
Low Price Target
$30.00
Potential Upside/Downside
+15.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.90
Trailing P/E Ratio
31.88
Forward P/E Ratio
17.60
P/E Growth
N/A
Net Income
$836 million
Net Margins
17.83%
Pretax Margin
23.69%
Return on Equity
155.48%
Return on Assets
9.12%

Debt

Debt-to-Equity Ratio
7.50
Current Ratio
0.48
Quick Ratio
0.48

Sales & Book Value

Annual Sales
$2.80 billion
Price / Sales
6.56
Cash Flow
$3.41 per share
Price / Cash Flow
8.42
Book Value
($0.16) per share
Price / Book
-179.31

Miscellaneous

Outstanding Shares
639,130,000
Free Float
618,038,000
Market Cap
$18.34 billion
Optionable
Optionable
Beta
0.84
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NYSE:GEN) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners